Trial intelligence / Profile preview

MMF vs Prednisolone in ICI-Induced Hepatitis

NCT04810156Phase 2Unknown

Start
Apr 2021
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mycophenolate mofetil in Drug-induced hepatitis (DILI). Status: unknown.

02

Drugs

mycophenolate mofetil
03

Conditions

Drug-induced hepatitis (DILI)

Beyond the preview

Go deeper on NCT04810156.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04810156.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call